Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01171118 · ClinicalTrials.gov registry record · NA
Phamacological Reversal of Airway Instability During Sedation
A NA study of Upper Airway Obstruction, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01171118 is a NA study of Upper Airway Obstruction that has completed, run by University of Rochester. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01171118, a NA study of Upper Airway Obstruction, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are attempting to demonstrate a decrease in the frequency and severity of sedation-induced respiratory arrhythmias(central and obstructive apneas) with pharmacological pre-treatment in this pilot project and then eventually to understand the mechanisms behind this decrease. The efficacy and mechanisms of these treatments, while evaluated during sleep in Obstructed Sleep Apnea (OSA) patients, have not been systematically studied during sedation in either normal subjects or OSA patients. The agent to be assessed in this study in physostigmine versus placebo.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Oxygen
- DRUG Physostigmine
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01171118
The ClinicalTrials.gov registry entry for NCT01171118 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Upper Airway Obstruction appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT01171118 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01171118 about?
NCT01171118 is a clinical study titled "Phamacological Reversal of Airway Instability During Sedation". The investigators are attempting to demonstrate a decrease in the frequency and severity of sedation-induced respiratory arrhythmias(central and obstructive apneas) with pharmacological pre-treatment in this pilot project and then eventually to understand the mechanisms behind this decrease. The eff...
What is the current status of trial NCT01171118?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2009-08. Estimated completion is 2011-08.
What conditions does trial NCT01171118 study?
This clinical trial studies the following conditions: Upper Airway Obstruction.
What interventions are being tested in trial NCT01171118?
The interventions under investigation include: Placebo (DRUG), Oxygen (DRUG), Physostigmine (DRUG).
Who is sponsoring clinical trial NCT01171118?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01171118 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.